- Home
- WELL vs TMO Comparison
WELL vs TMO Comparison
Compare WELL & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WELL | TMO |
|---|---|---|
| Founded | 1970 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Machinery/Components |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.1B | 164.3B |
| IPO Year | 1994 | 1996 |
Fundamental Metrics
Financial Performance| Metric | WELL | TMO |
|---|---|---|
| Price | $227.91 | $506.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 18 |
| Target Price | $224.38 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 3.3M | 2.1M |
| Earning Date | 04-28-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.40% | 0.40% |
| EPS Growth | N/A | ★ 7.32 |
| EPS | 1.02 | ★ 4.43 |
| Revenue | $10,838,034,000.00 | ★ $20,918,000,000.00 |
| Revenue This Year | $28.56 | $6.55 |
| Revenue Next Year | $6.97 | $5.11 |
| P/E Ratio | $218.93 | ★ $114.24 |
| Revenue Growth | ★ 35.63 | 14.47 |
| 52 Week Low | $148.97 | $401.45 |
| 52 Week High | $224.47 | $643.99 |
Technical Indicators
Market Signals| Indicator | WELL | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 66.20 | 64.44 |
| Support Level | $207.78 | $457.06 |
| Resistance Level | N/A | $520.66 |
| Average True Range (ATR) | 5.84 | 13.50 |
| MACD | 2.19 | 3.67 |
| Stochastic Oscillator | 98.33 | 85.87 |
Price Performance
Historical ComparisonAbout WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,800 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).